TuisABT • NYSE
add
Abbott Laboratories
Vorige sluiting
$132,57
Dagwisseling
$131,17 - $132,76
Jaarwisseling
$110,86 - $141,23
Markkapitalisasie
230,51 mjd USD
Gemiddelde volume
5,59 m
P/V-verhouding
16,54
Dividend-opbrengs
1,78%
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 11,14 mjd | 7,37% |
Bedryfskoste | 4,09 mjd | 3,13% |
Netto inkomste | 1,78 mjd | 36,64% |
Netto winsgrens | 15,97 | 27,25% |
Wins per aandeel | 1,26 | 10,53% |
EBITDA | 2,98 mjd | 13,85% |
Effektiewe belastingkoers | 17,26% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 7,28 mjd | 0,87% |
Totale bates | 84,00 mjd | 15,04% |
Totale aanspreeklikheid | 33,17 mjd | -0,86% |
Totale ekwiteit | 50,83 mjd | — |
Uitstaande aandele | 1,74 mjd | — |
Prys om te bespreek | 4,56 | — |
Opbrengs op bates | 6,64% | — |
Opbrengs op kapitaal | 8,68% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,78 mjd | 36,64% |
Kontant van bedrywe | 2,05 mjd | 4,44% |
Kontant van beleggings | -582,00 m | -28,48% |
Kontant van finansiering | -1,10 mjd | -38,69% |
Netto kontantverandering | 419,00 m | -40,40% |
Beskikbare kontantvloei | 1,27 mjd | -10,95% |
Meer oor
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide.
Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.
The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
Gestig
1888
Hoofkwartier
Webwerf
Werknemers
114 000
